Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 25, 2020	Sep. 25, 2020
Current assets:
Cash and cash equivalents	$ 1,110,024	$ 1,071,876
Restricted cash	9,401	8,103
Short-term investments	52,261	46,948
Accounts receivable, net of allowance for credit losses of $12,624 and $15,908	293,948	180,340
Contract assets, net of allowance for credit losses of $215 and $0	187,539	161,357
Inventories, net	20,108	25,550
Prepaid expenses and other current assets	51,390	53,022
Total current assets	1,724,671	1,547,196
Long-term investments	49,337	52,149
Property, plant, and equipment, net	543,550	541,963
Operating lease right-of-use assets	75,460	76,515
Intangible assets, net	144,688	152,431
Goodwill	338,713	336,945
Other non-current assets	86,825	91,245
Deferred taxes	133,610	118,881
Total assets	3,096,854	2,917,325
Current liabilities:
Accounts payable	13,631	12,617
Accrued liabilities	250,253	219,974
Income taxes payable	15,516	3,260
Contract liabilities	21,202	15,436
Operating lease liabilities	15,817	15,822
Total current liabilities	316,419	267,109
Non-current contract liabilities	23,766	24,342
Non-current operating lease liabilities	64,256	65,315
Other non-current liabilities	121,196	122,154
Total liabilities	525,637	478,920
Stockholders’ equity:
Retained earnings	2,565,670	2,443,138
Accumulated other comprehensive (loss)	(608)	(10,594)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,565,162	2,432,643
Controlling interest	6,055	5,762
Total stockholders’ equity	2,571,217	2,438,405
Total liabilities and stockholders’ equity	3,096,854	2,917,325
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 65,463,823 shares issued and outstanding at December 25, 2020 and 64,167,725 at September 25, 2020
Stockholders’ equity:
Common stock	59	58
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 36,127,720 shares issued and outstanding at December 25, 2020 and 36,128,720 at September 25, 2020
Stockholders’ equity:
Common stock	$ 41	$ 41